GoodRx Holdings, Inc. GDRX Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s additional paid-in capital?
- GoodRx Holdings, Inc. (GDRX) reported additional paid-in capital of $2.03B in Q1 2026.
- How has GoodRx Holdings, Inc.'s additional paid-in capital changed year-over-year?
- GoodRx Holdings, Inc.'s additional paid-in capital decreased by 2.5% year-over-year, from $2.08B to $2.03B.
- What is the long-term trend for GoodRx Holdings, Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s additional paid-in capital has grown at a -0.7% compound annual growth rate (CAGR), from $2.1B to $2.03B.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.